Alachua, Fla.-based RTI said it named director Jonathon Singer as its finance & administration chief effective Oct. 2, replacing Robert Jordheim. Singer, who resigned his board seat to accept the CFAO role, is the former CFO of Teleflex (NYSE:TFX), Sargent Pharmaceuticals and radiation safety products maker Landauer.
“As we continue to implement our long-term growth strategy, we need the right team to accelerate and solidify our progress,” CEO Camille Farhat said in prepared remarks. “I am particularly proud to welcome Jonathon who already has been a valuable contributor to RTI’s progress as one of our board members. His intricate knowledge of RTI combined with his broad business experience and deep background in strategic planning, finance, operations, IT, investor communications and business development will bring a new dimension to his role and help us accomplish the significant work ahead of us.
“I would like to extend my appreciation and gratitude to Rob Jordheim for his service as CFO and interim CEO,” Farhat added. “His commitment to RTI’s mission has contributed to putting us back on the path toward growth. We all wish Rob the best in his future endeavors.”
RTI also named Olivier Visa, former global compounding VP at Baxter (NYSE:BAX), as OEM, donor services & sports president. The company also tapped ex-American Medical Systems global quality VPs Julius Aviza as quality VP.
“Olivier and Julius are highly experienced executives with proven success in the health care sector who share our values of a customer-focused culture built around speed, competence, and predictable execution and growth,” Farhat said. “Olivier will be critical to furthering growth in RTI’s OEM business and driving operational excellence and profitability in its tissue business. Julius will work vigorously to ensure that our quality systems are at industry-leading standards while simplifying our processes to create a solid platform from which we can grow.”
Obalon recruits Huang for COO role
Obalon Therapeutics (NSDQ:OBLN) said it recruited Kelly Huang from Galderma Labs to be its new COO. Prior to Galderma Huang put in stints at Endo Pharmaceutical and Johnson & Johnson (NYSE:JNJ). Read more
- Rational Surgical Solutions names Murphy as COO
- Bonesupport lures Zimmer Biomet’s Chang as EVP of R&D
- Genel named skincare R&D director at Silk Therapeutics
- Ortho Sales Partners looks to Zimmber Biomet’s Hein for market dev VP slot
- 3B Medical fills sales & marketing VP, national sales director slots